The Life Sciences Innovative Manufacturing Fund (LSIMF) supports capital investment projects that increase the UK's manufacturing capacity and capability for life sciences products. The fund aims to improve health resilience, strengthen supply chains and support access to medicines, diagnostics and medical technologies.

Up to £520 million is available through the fund. Projects must have a total eligible cost of at least £8 million and may receive grant support of up to 25% of total project costs, with most awards expected to cover between 10% and 20% of project costs.

Applications are assessed through a multi-stage process, beginning with an Expression of Interest, followed by detailed assessment of health resilience benefits, project viability and value for money.

The fund is open until 31 March 2030. 

You may be eligible if you:

• are a UK registered company or a UK registered establishment with at least one UK registered company in your group structure
• are a product developer, contract development manufacturing organisation or generics manufacturer
• have a project with eligible costs of at least £8 million
• are investing in the manufacture of human medicines, medical diagnostics or medical technology products
• can demonstrate that grant funding is required for the project to proceed at the proposed scale, location or timeframe

Projects involving raw ingredient production, standalone single-use consumables or secondary packaging activities are not eligible. 

There is no cost to apply.

Successful applicants may receive grant funding towards eligible capital investment costs. Projects must have total eligible costs of at least £8 million. Grant support is available up to a maximum intervention rate of 25% of project costs.

This fund is for life sciences businesses that are investing in UK manufacturing facilities and infrastructure, including:

• pharmaceutical manufacturers
• product developers
• contract development and manufacturing organisations
• generics manufacturers
• medical diagnostics manufacturers
• medical technology (MedTech) manufacturers

Expressions of Interest can be submitted on a rolling basis.

Eligible applicants will be invited to further application stages, with application windows opening quarterly.

Timescales vary depending on project complexity and progression through the assessment process.

The fund is open until 31 March 2030.

Projects must support UK health resilience and deliver economic benefits such as increased GVA and high-skilled jobs.

Previous recipients of UK Government life sciences manufacturing grants may apply, provided they are applying for a different project.

Manufacturing facilities for medicines must comply with Good Manufacturing Practice (GMP) requirements. 

Visit the UK government Find a Grant website to find out more and apply.